Camrelizumab plus apatinib in patients with recurrent or metastatic nasopharyngeal carcinoma failing first-line therapy: An open-label, single-arm, phase II study X. Ding,W. Zhang,R. You,X. Zou, Z. Wang, Y-F. Ouyang, Y-L. Liu, L. Peng,L. You-Ping,C-Y. Duan, Q. Yang,C. Lin, X. Yulong,S-Y. Chen, C-M. Gu,P. Y. Huang,Y. Hua,M. ChenANNALS OF ONCOLOGY（2022）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
